BioNTech SE
Patents, Design & Utilities
Last updated:
List of all BioNTech SE patents 28 in total
| Status | Patent |
|---|---|
Grant | Utility: Multispecific antibodies against CD40 and CD137 Filling date: 26 Sep 2025 Issue date: 13 Sep 2022 |
Application | Utility: RNA CONSTRUCTS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: RECOMBINANT VACCINES AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: THERAPEUTIC RNA FOR OVARIAN CANCER Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: RNA CONSTRUCTS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Grant | Utility: Preparation and storage of liposomal RNA formulations suitable for therapy Filling date: 26 Sep 2025 Issue date: 26 Jul 2022 |
Application | Utility: SUBSTITUTED IMIDAZOQUINOLINES Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: TREATMENT INVOLVING INTERLEUKIN-2 (IL2) AND INTERFERON (IFN) Filling date: 26 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Recombinant vaccines and use thereof Filling date: 26 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: PREDICTING IMMUNOGENICITY OF T CELL EPITOPES Filling date: 26 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Substituted imidazoquinolines as agonists of TLR7 Filling date: 26 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Substituted imidazoquinolines Filling date: 26 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Filling date: 26 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: Individualized vaccines for cancer Filling date: 26 Sep 2025 Issue date: 15 Feb 2022 |
Application | Utility: MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Filling date: 26 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Predicting immunogenicity of T cell epitopes Filling date: 26 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: ANTIBODY FORMULATION Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: Engineered Cells for Inducing Tolerance Filling date: 26 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: Compositions and Methods for Diagnosis and Treatment of Cancer Filling date: 26 Sep 2025 Issue date: 12 Aug 2021 |
Grant | Utility: Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof Filling date: 26 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: SUBSTITUTED IMIDAZOQUINOLINES Filling date: 26 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Particles comprising protamine and RNA in combination with endosome destabilizing agents Filling date: 26 Sep 2025 Issue date: 4 Aug 2020 |
Showing 1 to 28 of 28 patents.